Asia-Pacific Medical Gases and Equipment market has been estimated at USD 4.02 Billion in 2018 and is projected to reach USD6.26 Billion by 2023 at a CAGR of 9.3% during the forecast period from 2018 to 2023. Medical gases and pharmaceutical gases are specialized gases used for medical purposes, drug processing and various applications of biotechnology. Medical gases include pure gases and mixture of gases for various medical processes.
The market for Medical Gases and Equipment is mainly driven due to Rise in the aging population, increasing incidence of COPD, increase in home healthcare, emerging economies. Also, technological innovation in the use of medical gases is also fuelling the market growth. But, the market growth can be restrained due to shortage of helium, largely concerning the manufacturers of medical equipment, and the stringent government rules and regulations.
Asia-Pacific market for Medical Gases and Equipment is segmented based on Product, Application and End-users. By Product, the market is further sub-segmented into Medical Gases (Pure Medical Gases by Type, by Form of Delivery), Medical Gas Mixtures (Blood Gas Mixtures, Lung Diffusion Mixtures, Nitrous Oxide-Oxygen Mixtures, Carbon Dioxide-Oxygen Mixtures, Laser Gas Mixtures, Aerobic Mixtures, Anaerobic Mixtures, Ethylene Oxide, Helium Oxygen Mixtures), Medical Gas Equipment (Equipment Accessories, Oxygen Concentrators, Gas Delivery Systems, Cryogenic Products (Freezers)). By Application, the market is further sub-segmented into Therapeutic (Respiratory Diseases, Cardiovascular Diseases, Anesthesia, Cryosurgery), Diagnostic, Pharmaceutical Manufacturing and Research. By End-users, the market is further sub-segmented into Hospitals, Home Healthcare, Emergency Services, Pharmaceutical Industry, Academic & Research Institutions.
Geographically, Asia-Pacific market for Medical Gases and Equipment is segmented into China, India, Japan, South Korea and Australia. The Medical Gases and Equipment market in the Asia-Pacific region is projected to grow at the highest CAGR, which is greatly due to increasing healthcare awareness, rising healthcare expenditures, growth in the aging population, and growth in per capita income.
Air Products and Chemicals, Inc., The Linde Group, Air Liquide, Praxair, Inc., Taiyo Nippon Sanso Corp., SOL-SpA, Airgas, Inc., Atlas Copco, Messer Group, GCE Holding AB, Beacon Medaes, Medical Gas Solutions Ltd., Matheson Tri-Gas, Taiya Nippon Sanso, Atlas Copco, are the major players of Asia-Pacific Medical Gases and Equipment market.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product
5.1.1 Introduction
5.1.2 Medical Gases
5.1.2.1 Pure Medical Gases, by Type
5.1.2.1.1 Oxygen
5.1.2.1.2 Carbon Dioxide
5.1.2.1.3 Nitrogen
5.1.2.1.4 Nitrous Oxide
5.1.2.1.5 Medical Air
5.1.2.1.6 Helium
5.1.2.2 Pure Medical Gases, by Form of Delivery
5.1.2.2.1 Pure Gases in High Pressure Cylinders
5.1.2.2.2 Pure Gases in Liquid Cylinders
5.1.2.2.3 Bulk Delivery
5.1.3 Medical Gas Mixtures
5.1.3.1 Blood Gas Mixtures
5.1.3.2 Lung Diffusion Mixtures
5.1.3.3 Nitrous Oxide-Oxygen Mixtures
5.1.3.4 Carbon Dioxide-Oxygen Mixtures
5.1.3.5 Laser Gas Mixtures
5.1.3.6 Aerobic Mixtures
5.1.3.7 Anaerobic Mixtures
5.1.3.8 Ethylene Oxide
5.1.3.9 Helium Oxygen Mixtures
5.1.4 Medical Gas Equipment
5.1.4.1 Equipment Accessories
5.1.4.1.1 Vacuum Systems
5.1.4.1.2 Manifolds
5.1.4.1.3 Regulators
5.1.4.1.4 Flowmeters
5.1.4.1.5 Suction Regulators
5.1.4.1.6 Hose
5.1.4.1.7 Outlets
5.1.4.1.8 Monitoring Systems (Alarms & Monitors)
5.1.4.2 Oxygen Concentrators
5.1.4.3 Gas Delivery Systems
5.1,4.4 Cryogenic Products (Freezers)
5.1.5 Y-o-Y Growth Analysis, By Product
5.1.6 Market Attractiveness Analysis, By Product
5.1.7 Market Share Analysis, By Product
5.2 Application
5.3.1 Introduction
5.3.2 Therapeutic
5.3.2.1 Respiratory Diseases
5.3.2.2 Cardiovascular Diseases
5.3.2.3 Anesthesia
5.3.2.4 Cryosurgery
5.3.3 Diagnostic
5.3.3.1 Medical Imaging
5.3.3.2 General Laboratory Use
5.3.4 Pharmaceutical Manufacturing and Research
5.3.4.1 Drug Discovery
5.3.4.2 Process Development
5.3.4.3 Manufacturing
5.3.4.4 Quality Control
5.3.5 Other Applications
5.3.6 Y-o-Y Growth Analysis, By Application
5.3.7 Market Attractiveness Analysis, By Application
5.3.8 Market Share Analysis, By Application
5.3 End-users
5.4.1 Introduction
5.4.2 Hospitals
5.4.3 Home Healthcare
5.4.4 Emergency Services
5.4.5 Pharmaceutical Industry
5.4.6 Academic & Research Institutions
5.4.7 Y-o-Y Growth Analysis, By End-users
5.4.8 Market Attractiveness Analysis, By End-users
5.4.9 Market Share Analysis, By End-users
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By Application
6.1.3.4 By End-users
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product
6.1.4.3 By Application
6.1.4.4 By End-users
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product
6.1.5.3 By Application
6.1.5.4 By End-users
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Air Products and Chemicals, Inc.
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 The Linde Group
8.3 Air Liquide
8.4 Praxair, Inc.
8.5 Taiyo Nippon Sanso Corp. &n
